(Q36862117)

16 August 2017

1 reference

title

Molecular biology of cervical cancer (English)

1 reference

16 August 2017

0 references

González Martín A

1

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Clinical and Translational Oncology

16 August 2017

published in

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

347-354

1 reference

https://scigraph.springernature.com/pub.10.1007/s12094-007-0066-8

16 August 2017

exact match

0 references

cites work

The insulin-like growth factor system and cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-007-0066-8

Inhibition of Bak-induced apoptosis by HPV-18 E6.

21 January 2018

1 reference

12 December 2020

Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer

1 reference

12 December 2020

The natural history of type-specific human papillomavirus infections in female university students.

1 reference

12 December 2020

Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression

1 reference

12 December 2020

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

12 December 2020

Immunological analyses of human papillomavirus capsids

1 reference

12 December 2020

Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein

1 reference

12 December 2020

The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.

1 reference

12 December 2020

Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein.

1 reference

12 December 2020

Kinetics of in vitro adsorption and entry of papillomavirus virions

1 reference

12 December 2020

Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer

1 reference

12 December 2020

Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma

1 reference

12 December 2020

Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins

1 reference

12 December 2020

Combined oral contraceptives and cervical cancer

1 reference

12 December 2020

Epigenetics of cervical cancer. An overview and therapeutic perspectives

1 reference

12 December 2020

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

1 reference

12 December 2020

The role of viral integration in the development of cervical cancer.

1 reference

12 December 2020

Chapter 5: Updating the natural history of HPV and anogenital cancer

1 reference

12 December 2020

The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors

1 reference

12 December 2020

Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.

1 reference

12 December 2020

Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers

1 reference

12 December 2020

Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.

1 reference

12 December 2020

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

12 December 2020

Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells

1 reference

12 December 2020

Symptomatic genital papillomavirus infection in a community. Incidence and clinical picture

1 reference

12 December 2020

The proteasome: a suitable antineoplastic target

1 reference

12 December 2020

The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer

1 reference

12 December 2020

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

1 reference

12 December 2020

Telomerase activation by the E6 gene product of human papillomavirus type 16.

1 reference

12 December 2020

Mechanisms of human papillomavirus-induced oncogenesis.

1 reference

12 December 2020

Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins

1 reference

12 December 2020

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

12 December 2020

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

1 reference

12 December 2020

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

1 reference

12 December 2020

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses

1 reference

12 December 2020

Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses

1 reference

12 December 2020

Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes

1 reference

12 December 2020

Assembly and translocation of papillomavirus capsid proteins

1 reference

12 December 2020

Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes

1 reference

12 December 2020

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

1 reference

12 December 2020

Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia

1 reference

12 December 2020

Chapter 2: The burden of HPV-related cancers

1 reference

12 December 2020

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

1 reference

12 December 2020

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

1 reference

12 December 2020

Chapter 1: HPV in the etiology of human cancer

1 reference

12 December 2020

Viruses, chemicals and co-carcinogenesis

1 reference

12 December 2020

Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells

1 reference

12 December 2020

E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice

1 reference

12 December 2020

Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines

1 reference

12 December 2020

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

1 reference

12 December 2020

The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains

1 reference

12 December 2020

10.1007/S12094-007-0066-8

Identifiers

DOI

1 reference

16 August 2017

1 reference